ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 106 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,308,026,000 | +559.3% | 714,432 | +293.6% | 0.00% | – |
| Q3 2019 | $653,451,000 | +41.1% | 181,514 | +5.0% | 0.00% | – |
| Q2 2019 | $463,192,000 | +77.2% | 172,833 | +95.7% | 0.00% | – |
| Q1 2019 | $261,427,000 | +97.3% | 88,320 | +6.0% | 0.00% | – |
| Q4 2018 | $132,479,000 | -56.8% | 83,320 | 0.0% | 0.00% | – |
| Q3 2018 | $306,618,000 | +30.0% | 83,320 | 0.0% | 0.00% | – |
| Q2 2018 | $235,795,000 | -20.1% | 83,320 | +4.8% | 0.00% | – |
| Q1 2018 | $295,019,000 | +58.5% | 79,520 | +23.0% | 0.00% | – |
| Q4 2017 | $186,160,000 | -35.9% | 64,639 | 0.0% | 0.00% | – |
| Q3 2017 | $290,229,000 | -0.7% | 64,639 | +1.5% | 0.00% | – |
| Q2 2017 | $292,241,000 | +29.3% | 63,669 | +18.6% | 0.00% | – |
| Q1 2017 | $225,947,000 | +186633.1% | 53,669 | +83.8% | 0.00% | – |
| Q4 2016 | $121,000 | -77.7% | 29,198 | -56.4% | 0.00% | -100.0% |
| Q3 2016 | $543,000 | +3.8% | 66,998 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $523,000 | +1.2% | 66,998 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $517,000 | -27.4% | 66,998 | +1.6% | 0.00% | 0.0% |
| Q4 2015 | $712,000 | -84.1% | 65,959 | -89.8% | 0.00% | -80.0% |
| Q3 2015 | $4,465,000 | -23.1% | 646,159 | -1.4% | 0.01% | -16.7% |
| Q2 2015 | $5,808,000 | -7.7% | 655,459 | +2.7% | 0.01% | 0.0% |
| Q1 2015 | $6,295,000 | -18.2% | 638,459 | +1.6% | 0.01% | -14.3% |
| Q4 2014 | $7,696,000 | +61.0% | 628,259 | +31.2% | 0.01% | +40.0% |
| Q3 2014 | $4,780,000 | +1188.4% | 478,959 | +878.3% | 0.01% | – |
| Q2 2014 | $371,000 | +130.4% | 48,959 | 0.0% | 0.00% | – |
| Q1 2014 | $161,000 | +21.1% | 48,959 | +21.9% | 0.00% | – |
| Q4 2013 | $133,000 | -97.9% | 40,159 | -98.1% | 0.00% | -100.0% |
| Q3 2013 | $6,348,000 | -51.1% | 2,102,065 | +32.6% | 0.01% | -52.9% |
| Q2 2013 | $12,971,000 | – | 1,585,765 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $82,075,000 | 8.82% |
| RTW INVESTMENTS, LP | 1,622,633 | $19,877,000 | 7.35% |
| ProQuest Associates IV LLC | 1,122,957 | $13,757,000 | 6.97% |
| RA Capital Management | 2,500,000 | $30,625,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 517,450 | $6,339,000 | 3.03% |
| DAFNA Capital Management LLC | 197,500 | $2,419,000 | 1.91% |
| Rhenman & Partners Asset Management AB | 368,000 | $4,508,000 | 1.31% |
| SECTORAL ASSET MANAGEMENT INC | 2,373,810 | $29,079,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,920,300 | $35,774,000 | 1.28% |
| Bain Capital Public Equity Management, LLC | 2,928,750 | $35,877,000 | 0.90% |